Cargando…

27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer

SIMPLE SUMMARY: Breast cancer is the most common cancer in women, and there is a known link between high cholesterol levels and breast cancer. However, how cholesterol impacts breast cancer is poorly understood, particularly in the case of an aggressive form of cancer known as estrogen receptor nega...

Descripción completa

Detalles Bibliográficos
Autores principales: Avena, Paola, Casaburi, Ivan, Zavaglia, Lucia, Nocito, Marta C., La Padula, Davide, Rago, Vittoria, Dong, Jing, Thomas, Peter, Mineo, Chieko, Sirianni, Rosa, Shaul, Philip W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946696/
https://www.ncbi.nlm.nih.gov/pubmed/35326671
http://dx.doi.org/10.3390/cancers14061521
_version_ 1784674254780891136
author Avena, Paola
Casaburi, Ivan
Zavaglia, Lucia
Nocito, Marta C.
La Padula, Davide
Rago, Vittoria
Dong, Jing
Thomas, Peter
Mineo, Chieko
Sirianni, Rosa
Shaul, Philip W.
author_facet Avena, Paola
Casaburi, Ivan
Zavaglia, Lucia
Nocito, Marta C.
La Padula, Davide
Rago, Vittoria
Dong, Jing
Thomas, Peter
Mineo, Chieko
Sirianni, Rosa
Shaul, Philip W.
author_sort Avena, Paola
collection PubMed
description SIMPLE SUMMARY: Breast cancer is the most common cancer in women, and there is a known link between high cholesterol levels and breast cancer. However, how cholesterol impacts breast cancer is poorly understood, particularly in the case of an aggressive form of cancer known as estrogen receptor negative breast cancer. Using cells in culture and models of breast tumors in mice, we have determined that an abundant metabolite of cholesterol known as 27-hydroxycholesterol stimulates estrogen receptor negative breast cancer growth. We have also determined how 27-hydroxycholesterol stimulates the growth, identifying a new mechanism of action of 27-hydroxycholesterol. These new findings may explain the link between high cholesterol and estrogen receptor negative breast cancer, and they may lead to the development of new therapies for a type of breast cancer that presently lacks specific treatments. ABSTRACT: Cholesterol affects the proliferation of breast cancer (BC) and in particular of estrogen receptor-negative (ER−) BC. Cholesterol is converted to 27-hydroxycholesterol (27HC), which promotes the growth of ER+ BC. Potentially, 27HC can be involved in cholesterol-dependent ER− BC proliferation. Stable MDA-MB-231 silenced clones for CYP7B1 (27HC metabolizing enzyme) show an increased basal proliferation rate, which is not observed in the presence of lipoprotein-deprived serum. Furthermore, the treatment of SKBR3, MDA-MB-231 and MDA-MB-468 with 27HC increased cell proliferation that was prevented by G15, a selective G Protein-Coupled Estrogen Receptor (GPER) inhibitor, suggested this receptor to be a potential 27HC target. Binding experiments demonstrate that 27HC is a new ligand for GPER. We show that ERK1/2 and NFκB are part of the 27HC/GPER pathway. The stable silencing of GPER prevents NFκB activation and reduces basal and 27HC-dependent tumor growth. Additionally, conditioned medium from ER− BC cells treated with 27HC promotes tube formation, which does not occur with CM from GPER silenced cells. Collectively, these data demonstrate that cholesterol conversion into 27HC promotes ER− BC growth and progression, and the expression of GPER is required for its effects.
format Online
Article
Text
id pubmed-8946696
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89466962022-03-25 27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer Avena, Paola Casaburi, Ivan Zavaglia, Lucia Nocito, Marta C. La Padula, Davide Rago, Vittoria Dong, Jing Thomas, Peter Mineo, Chieko Sirianni, Rosa Shaul, Philip W. Cancers (Basel) Article SIMPLE SUMMARY: Breast cancer is the most common cancer in women, and there is a known link between high cholesterol levels and breast cancer. However, how cholesterol impacts breast cancer is poorly understood, particularly in the case of an aggressive form of cancer known as estrogen receptor negative breast cancer. Using cells in culture and models of breast tumors in mice, we have determined that an abundant metabolite of cholesterol known as 27-hydroxycholesterol stimulates estrogen receptor negative breast cancer growth. We have also determined how 27-hydroxycholesterol stimulates the growth, identifying a new mechanism of action of 27-hydroxycholesterol. These new findings may explain the link between high cholesterol and estrogen receptor negative breast cancer, and they may lead to the development of new therapies for a type of breast cancer that presently lacks specific treatments. ABSTRACT: Cholesterol affects the proliferation of breast cancer (BC) and in particular of estrogen receptor-negative (ER−) BC. Cholesterol is converted to 27-hydroxycholesterol (27HC), which promotes the growth of ER+ BC. Potentially, 27HC can be involved in cholesterol-dependent ER− BC proliferation. Stable MDA-MB-231 silenced clones for CYP7B1 (27HC metabolizing enzyme) show an increased basal proliferation rate, which is not observed in the presence of lipoprotein-deprived serum. Furthermore, the treatment of SKBR3, MDA-MB-231 and MDA-MB-468 with 27HC increased cell proliferation that was prevented by G15, a selective G Protein-Coupled Estrogen Receptor (GPER) inhibitor, suggested this receptor to be a potential 27HC target. Binding experiments demonstrate that 27HC is a new ligand for GPER. We show that ERK1/2 and NFκB are part of the 27HC/GPER pathway. The stable silencing of GPER prevents NFκB activation and reduces basal and 27HC-dependent tumor growth. Additionally, conditioned medium from ER− BC cells treated with 27HC promotes tube formation, which does not occur with CM from GPER silenced cells. Collectively, these data demonstrate that cholesterol conversion into 27HC promotes ER− BC growth and progression, and the expression of GPER is required for its effects. MDPI 2022-03-16 /pmc/articles/PMC8946696/ /pubmed/35326671 http://dx.doi.org/10.3390/cancers14061521 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Avena, Paola
Casaburi, Ivan
Zavaglia, Lucia
Nocito, Marta C.
La Padula, Davide
Rago, Vittoria
Dong, Jing
Thomas, Peter
Mineo, Chieko
Sirianni, Rosa
Shaul, Philip W.
27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer
title 27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer
title_full 27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer
title_fullStr 27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer
title_full_unstemmed 27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer
title_short 27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer
title_sort 27-hydroxycholesterol binds gper and induces progression of estrogen receptor-negative breast cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946696/
https://www.ncbi.nlm.nih.gov/pubmed/35326671
http://dx.doi.org/10.3390/cancers14061521
work_keys_str_mv AT avenapaola 27hydroxycholesterolbindsgperandinducesprogressionofestrogenreceptornegativebreastcancer
AT casaburiivan 27hydroxycholesterolbindsgperandinducesprogressionofestrogenreceptornegativebreastcancer
AT zavaglialucia 27hydroxycholesterolbindsgperandinducesprogressionofestrogenreceptornegativebreastcancer
AT nocitomartac 27hydroxycholesterolbindsgperandinducesprogressionofestrogenreceptornegativebreastcancer
AT lapaduladavide 27hydroxycholesterolbindsgperandinducesprogressionofestrogenreceptornegativebreastcancer
AT ragovittoria 27hydroxycholesterolbindsgperandinducesprogressionofestrogenreceptornegativebreastcancer
AT dongjing 27hydroxycholesterolbindsgperandinducesprogressionofestrogenreceptornegativebreastcancer
AT thomaspeter 27hydroxycholesterolbindsgperandinducesprogressionofestrogenreceptornegativebreastcancer
AT mineochieko 27hydroxycholesterolbindsgperandinducesprogressionofestrogenreceptornegativebreastcancer
AT siriannirosa 27hydroxycholesterolbindsgperandinducesprogressionofestrogenreceptornegativebreastcancer
AT shaulphilipw 27hydroxycholesterolbindsgperandinducesprogressionofestrogenreceptornegativebreastcancer